Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 2, 2009, Pages 279-282

  Kudin, M V ^a   Tarasov, S A ^a   Kachanova, M V ^a   Skripkin, A V ^a   Fedorov, Yu N ^a  

^a Vol'skaya Central Regional Hospital

Author keywords

Acute respiratory viral infection; Adenoviral infection; Anaferon (pediatric formulation); Rotavirus infection

Indexed keywords

ANAFERON; ANTIVIRUS AGENT; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; BRONCHOPNEUMONIA; CHILD; CONTROLLED STUDY; DISEASE DURATION; DRUG HYPERSENSITIVITY; FEVER; HUMAN; INCIDENCE; INFECTION PREVENTION; INTOXICATION; MAJOR CLINICAL STUDY; MORBIDITY; RESPIRATORY TRACT INFECTION; ROTAVIRUS; VIRUS INFECTION;

ANTIBODIES; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERFERONS; MALE; RESPIRATORY TRACT INFECTIONS;

ROTAVIRUS;

EID: 74949089123     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0703-z     Document Type: Article

References (6)

1. O. L. Voronova, O. P. Rogosina, A. V. Martyushev, et al., Byull. Eksp. Biol. Med., Suppl., 75-77 (2003).
2. F. I. Ershov, Antiviral Preparations [in Russian], Moscow (1998).
3. L. V. Osidak, I. N. Zhilinskaya, V. P. Drinevskii, et al., Detskie Infektsii, No. 4, 54 (2004).
4. I. L. Shakhnina, L. A. Osipova, and O. I. Raduto, Epidemiol. Infect. Bol., No. 3, 58-60 (2001).
5. E. Yu. Sherstoboev, N. V. Masnaya, A. A. Churin, et al., Byull. Eksp. Biol. Med., Suppl., 78-80 (2003).
6. E. Yu. Sherstoboev, N. V. Masnaya, A. A. Churin, et al., Byull. Eksp. Biol. Med., Suppl., (2003). Ibid., pp. 81-84.